GLP1 Receptor Agonists

Ozempic Might Cut Risk Of Broken Bones, Study Says

Ozempic Might Cut Risk Of Broken Bones, Study Says

Dennis Thompson

Jun 19, 2026

2 min read

ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment

ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment

Jun 17, 2026

2 min read

ENDO: Significant Decrease in Physical Activity Seen After GLP-1 Receptor Agonist Initiation

ENDO: Significant Decrease in Physical Activity Seen After GLP-1 Receptor Agonist Initiation

Jun 17, 2026

1 min read

Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs

Cardiovascular Diseases

Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs

Dennis Thompson

Jun 17, 2026

2 min read

ADA: Orforglipron Beneficial for Reducing HbA1c in Type 2 Diabetes

ADA: Orforglipron Beneficial for Reducing HbA1c in Type 2 Diabetes

Jun 16, 2026

2 min read

People Walk, Exercise Less After Starting Ozempic, Zepbound

People Walk, Exercise Less After Starting Ozempic, Zepbound

Dennis Thompson

Jun 16, 2026

2 min read

ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds

ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds

Jun 15, 2026

1 min read

GLP-1 Receptor Agonist Use Linked to Lower Incidence of Obesity-Associated Cancers

GLP-1 Receptor Agonist Use Linked to Lower Incidence of Obesity-Associated Cancers

Jun 11, 2026

1 min read

Continuation of GLP-1 Receptor Agonist Use in Early Pregnancy Seems Safe

Continuation of GLP-1 Receptor Agonist Use in Early Pregnancy Seems Safe

Jun 10, 2026

1 min read

Read More

www.healthday.com